The 10th Annual
Drug Repositioning and Repurposing Conference
About the Conference
Key Subjects Covered at This Event
Patient Advocacy Efforts
Emphasis on and engagement with patient advocacy groups, who are investing in drug repositioning efforts to an unprecedented degree.
Artificial intelligence and other technologies are quickly reshaping drug discovery and development. This event will showcase how they are reshaping the field of drug repurposing.
The conference will explore how new partnerships between various groups, including government, industry and academia are advancing repurposing.
Regulatory and Legal Guidance
Legal, IP and regulatory guidance will be shared with the audience, including knowlege and insight into the 505(b)(2) regulatory pathway.
Systematic Repositioning & Data Analytics
Repurposing is no longer based on serendipity as more and more companies are designing tools to streamline and increase the odds of success.
Key Therapeutic Areas for Repurposing
Repurposing is beginning to make its mark in a range of therapeutic areas in need of new therapies. Rare and orphan diseases, tropical diseases and cancer will be discussed in terms of repurposing efforts currently underway.
Why You Should Attend
Partnering Software & Meetings
Discover & Learn
Past Sponsors & Exhibitors
What Past Attendees Have to Say
"Great conference for anyone considering or doing drug repurposing. A range of approaches and aspects are covered well."
"Excellent speakers, interested delegates, scientifically solid content, delicious food! One of my best conference experiences this year!"
"Following the tradition of almost a decade of excellent content, the drug repositioning conference is a Must Attend event and for good reason. Especially in our Covid-19 era. Looking forward to the Decade anniversary in 2021.“
"Every year I come to this conference I see ast least 1-2 presentations by people that are absolutely incredible. These people are literally chaning the world for the better."
"The DRRR brings together all the stakeholders in drug repurposing to learn from each other, collaborate, and create the future of repurposing research."